Hormonal
Oral semaglutide at 7 mg/d and 14 mg/d, when added to metformin with or without sulfonylurea, significantly reduces glycated hemoglobin (HbA1c) and body weight compared to sitagliptin in adults with type 2 diabetes.
If you have type 2 diabetes that isn't well-controlled with metformin (with or without sulfonylurea), adding oral semaglutide at 7 mg or 14 mg daily can significantly lower your HbA1c and help you lose weight compared to taking sitagliptin. Start with 3 mg, then increase to 7 mg after 4 weeks, and finally to 14 mg after another 4 weeks. Take it first thing in the morning with water, at least 30 minutes before eating or taking other medications. The 3 mg dose alone is not effective for lowering HbA1c compared to sitagliptin, so sticking to the higher doses is important.
Semaglutide, 7 and 14 mg/d, compared with sitagliptin, significantly reduced HbA1c (differences, –0.3% [95% CI, –0.4% to –0.1%] and –0.5% [95% CI, –0.6% to –0.4%], respectively; P < .001 for both) and body weight (differences, –1.6 kg [95% CI, –2.0 to –1.1 kg] and –2.5 kg [95% CI, –3.0 to –2.0 kg], respectively; P < .001 for both) from baseline to week 26.
Why this rating
Phase 3, randomized, double-blind, double-dummy, parallel-group clinical trial with a large sample size (n=1864) and rigorous statistical analysis.
Source
Effect of Additional Oral Semaglutide vs Sitagliptin on Glycated Hemoglobin in Adults With Type 2 Diabetes Uncontrolled With Metformin Alone or With Sulfonylurea
Julio Rosenstock et al. · JAMA · 2019
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →